Roche said in a statement that it had joined forces with Gilead for a global phase III clinical trial evaluating the safety and efficacy of using tocilizumab combined with remdesivir in hospitalised patients with severe Covid-19 pneumonia.
from Hindustan Times - world https://ift.tt/36Qz7qx
No comments:
Post a Comment